The Need for Speed
August 3, 2026
Why vertical integration is the key to streamlining complex retina clinical trials
5 min read
False
Discover the voices driving change and progress in ophthalmology – from legacy figures to today’s leading professionals, explore stories, interviews, and community highlights that inspire and inform.
Professor of Ophthalmology, UCL; Consultant Ophthalmologist, Moorfields Eye Hospital NHS Trust, UK
View Profile
Founding Director, RIIO iHospital and RIIO School of Ophthalmology, Rwanda, Africa; President, African Ophthalmology Council (AOC), Africa
View Profile
Leading 2026 Power Lister Gus Gazzard on collaboration, data quality, and trial design
Innovations in patient care and practice management
Jul 03, 2026
By Rod Solar
Why do so many practice owners still feel like they're constantly firefighting?
5 min read
Your hub for career growth and professional resources
Mar 20, 2026
By Andrzej Grzybowski
A collaborative platform for myopia experts in Europe
3 min read
March 12, 2026
3 min read
The latest events and developments shaping the field.
1/28/2026
Join us for a deep dive into canaloplasty in the era of interventional glaucoma or IG.
2/11/2025
Join Leica Microsystems' Online Cataract Surgery Symposium.
8/26/2026
Join us for an expert-led discussion on EndoArt, the first and only artificial endothelial layer designed for chronic corneal edema due to endothelial dysfunction.
All the latest across ophthalmology.
August 4, 2026
First patient enrolled in US pilot study for age-related cataract
2 min read
August 4, 2026
Survey questions what drives geographic atrophy treatment decisions for clinicians
2 min read
August 3, 2026
Sitting Down With… Joan W. Miller, David Glendenning Cogan Professor of Ophthalmology, Harvard Medical School; Retina Service, Mass Eye and Ear; Founder, Joan W. Miller AMD Research Group at Mass Eye and Ear
3 min read
August 3, 2026
Why vertical integration is the key to streamlining complex retina clinical trials
5 min read
July 31, 2026
Study questions whether a pre-existing osteoporosis drug could reduce glaucoma and ocular hypertension risk
2 min read
July 31, 2026
BioMed X and Boehringer launch new eye therapy research team
2 min read
July 30, 2026
An overview of nonclinical data supporting vorolanib’s multi-mechanism of action (MOA) and key findings from the phase 2 DAVIO 2 and VERONA clinical trials, presented at the 44th Annual American Society of Retina Specialists Meeting (July 15–18, 2026; Montréal, Canada).
6 min read
July 29, 2026
Georgia State and Columbia University researchers win $6.5m NIH grant to advance treatment for rare inherited eye disease
2 min read
July 29, 2026
Timing is everything in retinal detachment repair, new study reports
2 min read
July 28, 2026
Recently published paper examines estrogen’s role in keratoconus
2 min read
False